IA par-ci, IA par là. L’intelligence artificielle est aujourd’hui incontournable et devient un argument de vente : « Notre produit à la pointe de la technologie utilise de l’IA ». A l’instar du « greenwashing », peut-on parler d’AI-washing ? Aux Etats-Unis, la SEC a récemment sanctionné plusieurs sociétés pour avoir fait croire à leurs clients qu’ils utilisaient des outils d’intelligence
Critical and Emerging Technologies (CET) are of vital importance to the U.S. government. Therefore, it has made CET funding and support a top priority.
The U.S. National Security Strategy identifies expanding economic prosperity and opportunity as one of three primary goals.
The following critical and emerging technology areas are deemed of critical importance to U.S.
On 8 October 2024, the UK government launched the new Regulatory Innovation Office (RIO), which aims to “reduce the burden of red tape” faced by businesses when bringing innovations to market, including artificial intelligence (AI) healthcare technologies and engineering biology products such as vaccines and cultivated meat.
The RIO, established within the Department of Science,
In the world of False Claims Act (“FCA”) litigation, the recent case United States ex rel. Robert C. O’Laughlin, M.D. v. Radiation Therapy Services, P.S.C., et al. serves as an important reminder of the need for concrete evidence when asserting qui tam FCA claims.
California’s new law, SB 1120, set to take effect on January 1, 2025, regulates how health care service plans (HCSPs) and disability insurers use automated decision-making tools, such as artificial intelligence, to analyze medical necessity in utilization reviews affecting California enrollees. Compared to federal guidelines, this law is more prescriptive, requiring HCSPs and disability
Earlier this week, the EMA published its Reflection paper on the use of AI in the medicinal product life cycle. As set out in our previous blog post, the EMA’s draft reflection paper was published for consultation in July 2023, and following many months of review of the feedback collected from the relevant stakeholders,
The United States District Court for the Eastern District of Michigan recently dismissed a False Claims Act (“FCA”) lawsuit brought against the City of Detroit. The core issue in United States ex rel. Lynn v. City of Detroit revolved around Detroit’s annual certifications and assurances to comply with federal laws and regulations as a condition
Leveraging AI in healthcare requires vast amounts of data, but navigating privacy and data security laws is crucial. A recent investigation into Australia’s I-MED Radiology Network highlights concerns about using medical data for AI. This case offers valuable insights for U.S. providers, especially regarding compliance with HIPAA and other regulations. Read more.
The Office of the Attorney General of Texas (“OAG”) announced a “first-of-its-kind healthcare generative AI” settlement with Pieces Technology, Inc. (“Pieces”). The settlement related to the Texas OAG allegations that Piece’s advertising and marketing claims about the accuracy of its generative artificial intelligence (GenAI) products in violation of the Texas Deceptive Trade Practices – Consumer
United States of America v. Sutter Health is exemplary of the delicate balance courts must strike when dealing with attorney-client privilege. Here, the United States District Court for the Northern District of California denied the relator’s motion for determination as to waiver of privilege, but granted alternative relief.
This case involves alleged violations of